Deutsche Bank AG downgraded shares of Teleflex Incorporated (NYSE:TFX) from a buy rating to a hold rating in a research report report published on Tuesday. They currently have $251.00 price objective on the medical technology company’s stock.
Several other analysts also recently issued reports on TFX. BidaskClub downgraded Teleflex from a buy rating to a hold rating in a research note on Monday, July 31st. Jefferies Group LLC restated a buy rating and issued a $230.00 price target on shares of Teleflex in a research note on Thursday, August 3rd. Needham & Company LLC restated a buy rating on shares of Teleflex in a research note on Friday, August 4th. Zacks Investment Research downgraded Teleflex from a buy rating to a hold rating in a research report on Thursday, August 24th. Finally, KeyCorp reiterated a hold rating on shares of Teleflex in a research report on Wednesday, September 6th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of $274.44.
Teleflex (TFX) traded up $2.77 on Tuesday, reaching $266.21. The company had a trading volume of 235,504 shares, compared to its average volume of 260,646. The company has a market cap of $11,870.00, a P/E ratio of 31.71, a PEG ratio of 2.20 and a beta of 1.05. Teleflex has a twelve month low of $142.97 and a twelve month high of $266.45. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70.
Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 2nd. The medical technology company reported $2.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.01 by $0.11. The business had revenue of $534.70 million during the quarter, compared to the consensus estimate of $522.94 million. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The firm’s quarterly revenue was up 17.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.80 EPS. sell-side analysts predict that Teleflex will post 8.34 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This report was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/17/deutsche-bank-ag-lowers-teleflex-incorporated-tfx-to-hold.html.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th will be issued a dividend of $0.34 per share. The ex-dividend date is Tuesday, November 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.51%. Teleflex’s dividend payout ratio (DPR) is currently 24.55%.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $237.18, for a total transaction of $47,436.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,916,414.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have sold a total of 600 shares of company stock valued at $138,162 in the last three months. 2.39% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. IFM Investors Pty Ltd acquired a new position in Teleflex in the 3rd quarter worth about $338,000. Coldstream Capital Management Inc. acquired a new position in Teleflex in the 3rd quarter worth about $226,000. California Public Employees Retirement System increased its holdings in Teleflex by 5.3% in the 3rd quarter. California Public Employees Retirement System now owns 102,182 shares of the medical technology company’s stock worth $24,725,000 after purchasing an additional 5,182 shares in the last quarter. Bamco Inc. NY increased its holdings in Teleflex by 17.2% in the 3rd quarter. Bamco Inc. NY now owns 137,140 shares of the medical technology company’s stock worth $33,184,000 after purchasing an additional 20,138 shares in the last quarter. Finally, Cubist Systematic Strategies LLC increased its holdings in Teleflex by 1,300.9% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 4,469 shares of the medical technology company’s stock worth $1,081,000 after purchasing an additional 4,150 shares in the last quarter. 90.45% of the stock is owned by institutional investors and hedge funds.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.